|
|
|
|
||
Consolidated & scheduling order. Looks like everything is on track ?WHEREAS Plaintiff Corcept Therapeutics, Inc. (“Corcept”) filed Civil Action No. 18- 03632 in this Judicial District against Defendant Teva Pharmaceuticals (USA) Inc. (“Teva”) on March 15, 2018; WHEREAS Corcept filed Civil Action No. 19-5066 in this Judicial District against Teva on February 8, 2019; WHEREAS Civil Action Nos. 18-3632 and 19-5066 were consolidated on February 21, 2019; WHEREAS Corcept filed Civil Action No. 19-21384 against Teva in this Judicial District on December 13, 2019; WHEREAS Teva now requests that Civil Action Nos. 18-3632 and 19-21384 be consolidated, and Corcept does not object,IT IS on this _______ day of __________, 2020, ORDERED that Civil Action Nos. 18-3632 and 19-21384 (the “Consolidated Actions”) are consolidated for all purposes; IT IS FURTHER ORDERED that all filings going forward shall be filed in Civil Action No. 18-3632 and that Civil Action No. 19-21384 shall be administratively terminated by the Clerk’s office; IT IS FURTHER ORDERED that the Consolidated Actions shall proceed on the following schedule: April 17, 2020 Teva serves non-infringement and invalidity contentions for ’216 patent May 11, 2020 Substantial completion of document production (does not include production accompanying Corcept’s contentions on ’216 patent) June 1, 2020 Corcept serves infringement contentions and response to invalidity contentions for ’216 patent June 19, 2020 Close of fact discovery August 1, 2020 Expiration of 30-month stay August 7, 2020 Opening expert reports on issues for which the party bears the burden of proof September 25, 2020 Rebuttal expert report October 27, 2020 Reply expert reports December 15, 2020 Close of expert discovery December 22, 2020 Deadline to file Daubert Motions January 12, 2021 Final Pretrial Order To be determined Final Pretrial Conference February 2, 2021 Trial Begins (7 days) |
return to message board, top of board |